Thrombospondin-1 is a major activator of TGF-β in fibrotic renal disease in the rat in vivo
- 1 February 2004
- journal article
- Published by Elsevier in Kidney International
- Vol. 65 (2), 459-468
- https://doi.org/10.1111/j.1523-1755.2004.00395.x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Smad proteins and transforming growth factor-β signalingKidney International, 2000
- Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivoKidney International, 1999
- Thrombospondin-1 Is a Major Activator of TGF-β1 In VivoCell, 1998
- The Fibronectin Production Is Increased by Thrombospondin via Activation of TGF-β in Cultured Human Mesangial CellsNephron, 1998
- Mesangial cell-derived transforming growth factor-β1 reduces macrophage adhesiveness with consequent deactivationKidney International, 1996
- Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivoKidney International, 1995
- Transfer of a mutated gene encoding active transforming growth factor-β1 suppresses mitogenesis and IL-1 response in the glomerulusKidney International, 1995
- Control of transforming growth factor-β activity: Latency vs. activationProgress in Growth Factor Research, 1992
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992
- Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.Journal of Clinical Investigation, 1991